Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection

Asmaa Samy,Afnan Hassan,Nesrine M. Hegazi,Mai Farid,Moustafa Elshafei
DOI: https://doi.org/10.1038/s41598-024-60721-3
IF: 4.6
2024-05-29
Scientific Reports
Abstract:COVID-19 is a global pandemic that caused a dramatic loss of human life worldwide, leading to accelerated research for antiviral drug discovery. Herbal medicine is one of the most commonly used alternative medicine for the prevention and treatment of many conditions including respiratory system diseases. In this study, a computational pipeline was employed, including network pharmacology, molecular docking simulations, and molecular dynamics simulations, to analyze the common phytochemicals of ginger rhizomes and identify candidate constituents as viral inhibitors. Furthermore, experimental assays were performed to analyze the volatile and non-volatile compounds of ginger and to assess the antiviral activity of ginger oil and hydroalcoholic extract. Network pharmacology analysis showed that ginger compounds target human genes that are involved in related cellular processes to the viral infection. Docking analysis highlighted five pungent compounds and zingiberenol as potential inhibitors for the main protease (M pro ), spike receptor-binding domain (RBD), and human angiotensin-converting enzyme 2 (ACE2). Then, (6)-gingerdiacetate was selected for molecular dynamics (MD) simulations as it exhibited the best binding interactions and free energies over the three target proteins. Trajectories analysis of the three complexes showed that RBD and ACE2 complexes with the ligand preserved similar patterns of root mean square deviation (RMSD) and radius of gyration (Rg) values to their respective native structures. Finally, experimental validation of the ginger hydroalcoholic extract confirmed the existence of (6)-gingerdiacetate and revealed the strong antiviral activity of the hydroalcoholic extract with IC of 2.727 . Our study provides insights into the potential antiviral activity of (6)-gingerdiacetate that may enhance the host immune response and block RBD binding to ACE2, thereby, inhibiting SARS-CoV-2 infection.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to predict the antiviral activity of ginger components against coronavirus infection through network pharmacology, molecular docking simulation and molecular dynamics analysis. Specifically, the research aims to: 1. **Analyze common phytochemicals in ginger**: Determine which components may act as virus inhibitors. 2. **Evaluate the antiviral potential of these components**: Especially for the main protease (Mpro), spike receptor - binding domain (RBD) of the novel coronavirus and human angiotensin - converting enzyme 2 (ACE2). 3. **Verify the antiviral activity of ginger extract**: Confirm the antiviral effect of ginger hydroalcoholic extract by experimental methods. ### Research Background - **SARS - CoV - 2**: It has led to a global pandemic, causing huge casualties and accelerating the research and development of antiviral drugs. - **Ginger (Zingiber officinale)**: It is a commonly used herb with multiple pharmacological effects, including anti - cancer, anticoagulant, anti - inflammatory, antioxidant, antifungal and antibacterial effects. Many studies have shown that ginger compounds have antiviral activity against a variety of viruses. ### Research Methods 1. **Network pharmacology analysis**: - Collect common phytochemicals in ginger and use Lipinski's Rule of Five (RO5) to screen compounds that meet the absorption, distribution, metabolism and excretion (ADME) criteria. - Use multiple databases (such as SEA, TargetNet, SwissTargetPrediction) to collect target genes of these compounds and map the query results to HUGO Gene Nomenclature Committee (HGNC) gene symbols. - Construct a ginger - chemical - target gene network and perform protein - protein interaction (PPI) analysis. 2. **Molecular docking simulation**: - Select the main protease (Mpro), spike receptor - binding domain (RBD) and human ACE2 as target proteins. - Use Molecular Operating Environment (MOE) software to prepare proteins and ligands and perform docking simulations. - Evaluate the binding affinity of ginger compounds with these target proteins. 3. **Molecular dynamics simulation**: - Select the compound with the best binding affinity, (6) - ginger diacetate, for 100 - nanosecond molecular dynamics simulation to verify its stable binding ability on different target proteins. 4. **Experimental verification**: - Analyze the components of ginger volatile oil and hydroalcoholic extract by gas chromatography - mass spectrometry (GC - MS) and liquid chromatography - tandem mass spectrometry (LC - MS/MS). - Evaluate the cytotoxicity and antiviral activity of ginger extract by MTT cytotoxicity assay and antiviral activity assay. ### Main Findings - **Network pharmacology analysis**: Ginger compounds target cellular processes related to virus infection. - **Molecular docking analysis**: Five pungent compounds and zingiberenol were identified as potential Mpro, RBD and ACE2 inhibitors. - **Molecular dynamics simulation**: (6) - ginger diacetate showed the best binding interaction and free energy on the three target proteins. - **Experimental verification**: (6) - ginger diacetate exists in ginger hydroalcoholic extract and shows strong antiviral activity with an IC50 value of 2.727 µg/ml. ### Conclusion This study provides evidence that ginger components (especially (6) - ginger diacetate) may enhance the host immune response and prevent the binding of RBD to ACE2, thereby inhibiting SARS - CoV - 2 infection. This provides valuable clues for the development of new antiviral drugs.